Cargando…
Inhibition of Bruton’s tyrosine kinase interferes with pathogenic B-cell development in inflammatory CNS demyelinating disease
Anti-CD20-mediated B-cell depletion effectively reduces acute multiple sclerosis (MS) flares. Recent data shows that antibody-mediated extinction of B cells as a lasting immune suppression, harbors the risk of developing humoral deficiencies over time. Accordingly, more selective, durable and revers...
Autores principales: | Torke, Sebastian, Pretzsch, Roxanne, Häusler, Darius, Haselmayer, Philipp, Grenningloh, Roland, Boschert, Ursula, Brück, Wolfgang, Weber, Martin S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498502/ https://www.ncbi.nlm.nih.gov/pubmed/32761407 http://dx.doi.org/10.1007/s00401-020-02204-z |
Ejemplares similares
-
Bruton’s Tyrosine Kinase Inhibition Promotes Myelin Repair
por: Martin, Elodie, et al.
Publicado: (2020) -
Bruton’s Tyrosine Kinase Inhibitors in Multiple Sclerosis: Pioneering the Path Towards Treatment of Progression?
por: Geladaris, Anastasia, et al.
Publicado: (2022) -
High-Dose Vitamin D-Mediated Hypercalcemia as a Potential Risk Factor in Central Nervous System Demyelinating Disease
por: Häusler, Darius, et al.
Publicado: (2020) -
IL-10-providing B cells govern pro-inflammatory activity of macrophages and microglia in CNS autoimmunity
por: Geladaris, Anastasia, et al.
Publicado: (2023) -
Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease
por: Häusler, Darius, et al.
Publicado: (2018)